Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 645

1.

Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.

Chrysant SG, Germino FW, Neutel JM.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):375-89. doi: 10.2165/11636080-000000000-00000. Review.

PMID:
23116225
3.

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.

Chrysant SG, Lee J, Melino M, Karki S, Heyrman R.

J Hum Hypertens. 2010 Nov;24(11):730-8. doi: 10.1038/jhh.2010.5. Epub 2010 Feb 18.

4.

Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.

Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, Maa JF.

Ther Adv Cardiovasc Dis. 2010 Aug;4(4):209-21. doi: 10.1177/1753944710374745. Epub 2010 Jun 2.

PMID:
20519261
5.
6.

Olmesartan/amlodipine: a review of its use in the management of hypertension.

Kreutz R.

Vasc Health Risk Manag. 2011;7:183-92. doi: 10.2147/VHRM.S16852. Epub 2011 Mar 29. Review.

7.

Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.

Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.

Clin Drug Investig. 2007;27(8):545-58.

PMID:
17638395
8.

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.

Chrysant SG, Marbury TC, Robinson TD.

J Hum Hypertens. 2003 Jun;17(6):425-32.

PMID:
12764406
9.

Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.

Rump LC, Sellin L.

Expert Opin Pharmacother. 2010 Sep;11(13):2231-42. doi: 10.1517/14656566.2010.510834. Review.

PMID:
20707758
10.

Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.

Parati G, Ochoa JE, Ramos C, Hoshide S, Lonati L, Bilo G.

Ther Adv Cardiovasc Dis. 2010 Oct;4(5):301-13. doi: 10.1177/1753944710380228. Review.

PMID:
20921092
11.

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.

Smith DH, Dubiel R, Jones M.

Am J Cardiovasc Drugs. 2005;5(1):41-50. Erratum in: Am J Cardiovasc Drugs. 2005;5(3):209.

PMID:
15631537
12.

Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.

Malacco E, Omboni S, Mallion JM, Volpe M; ESPORT Study Group.

High Blood Press Cardiovasc Prev. 2012 Dec;19(4):213-22. doi: 10.1007/BF03297633. Epub 2013 Feb 19.

PMID:
23430666
13.

Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.

Germino FW, Neutel JM, Dubiel R, Maa JF, Chavanu KJ.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):325-33. doi: 10.2165/11635000-000000000-00000.

PMID:
22920048
15.

Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.

Tocci G, Paneni F, Passerini J, Volpe M.

Expert Opin Pharmacother. 2012 Dec;13(18):2687-97. doi: 10.1517/14656566.2012.745510. Epub 2012 Nov 21. Review.

PMID:
23170911
16.

A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.

Weir MR, Hsueh WA, Nesbitt SD, Littlejohn TJ 3rd, Graff A, Shojaee A, Waverczak WF, Qian C, Jones CJ, Neutel JM.

J Clin Hypertens (Greenwich). 2011 Jun;13(6):404-12. doi: 10.1111/j.1751-7176.2011.00437.x. Epub 2011 Feb 5.

17.

Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.

Rosenbaum D, Girerd X.

Curr Med Res Opin. 2012 Feb;28(2):179-86. doi: 10.1185/03007995.2011.644626. Epub 2012 Jan 9.

PMID:
22114906
18.
20.

Supplemental Content

Support Center